Volume 43, Issue 7, Page 11 (July 2009)
13 of 30
PREVIEW
FULL TEXT
FULL-TEXT PDF (572 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
The Food and Drug Administration has approved an ophthalmic formulation of a fluoroquinolone antibiotic, besifloxacin, for the treatment of bacterial conjunctivitis.
PII: S0031-398X(09)70199-7
© 2009 Elsevier Inc. All rights reserved.
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
PREVIEW